Structure (Glycopyrrolate Injection Usp 1)
Glycopyrrolate Injection
Product Images NDC 70121-1397
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70121-1397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Glycopyrrolate Injection Usp 2)
This is a description for an injectable medication called Glycopyrrolate. The text includes dosage information for healthcare professionals and notes that it should be used intravenously or intramuscularly. The medication comes in a single dose vial and contains benzyl alcohol.*
1 (Glycopyrrolate Injection Usp 3)
This is a description of a medication containing Water for Injection, USP and Benzyl Alcohol, NF used for intravenous administration. It is a prescription drug that is available in 25 x 1 mL single dose vials. The medication is produced by Amneal Pharmaceuticals LLC and requires refrigeration between 20° to 25°C (68° to 77°F). The usual dosage and other important information can be found in the accompanying descriptive literature. The medication is pH adjusted with hydrochloric acid and/or sodium hydroxide.*
2 (Glycopyrrolate Injection Usp 4)
This is a label of a Glycopyrrolate injection solution intended for intramuscular or intravenous use containing 0.2 mg/mL in a 2 mL single dose vial which has benzyl alcohol.*
2 (Glycopyrrolate Injection Usp 5)
1 (Glycopyrrolate Injection Usp 6)
5 (Glycopyrrolate Injection Usp 7)
Glycopyrrolate Injection, USP is a prescription-only product containing 0.2 mg/mL of glycopyrrolate. It is available in 25 x 5 mL multiple-dose vials and is stored at 20-25°C. The injection includes water for injection, USP, and benzyl alcohol, NF (preservative) 0.9%. The pH is adjusted, when necessary, with hydrochloric acid and/or sodium hydroxide. The usual dosage can be found in the accompanying descriptive literature. This product is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ, USA.*
20 (Glycopyrrolate Injection Usp 8)
20 (Glycopyrrolate Injection Usp 9)
NDC 70121-1397-7 is a multiple dose vial containing 0.2 mg/mL glycopyrrolate injection intended for intramuscular or intravenous administration. Usage in newborns is not recommended due to the presence of benzyl alcohol. The solution is made up of Water for Injection, USP, with a preservative of Benzyl Alcohol, NF, pH adjusted with hydrochloric acid and/or sodium hydroxide. The accompanying descriptive literature should be consulted for the usual dosage. The range of storage temperature is 20°C to 25°C (68°F to 77°F). The product is manufactured by Amneal Pharmaceuticals in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
